This cost-effectiveness analysis assesses the lifetime health benefits and costs of invitation to 1-time Helicobacter pylori stool antigen testing added to biennial fecal immunochemical test (FIT) screening compared with FIT alone.
| # | Наименование новости | Тональность | Информативность | Дата публикации |
|---|---|---|---|---|
| 1 | E coli-produced HPV vaccine effective against cancer-causing strains of HPV | 0 | 14.22 | 08-07-2026 |
| 2 | Cost-Effectiveness of Perioperative Pembrolizumab in Locally Advanced Head and Neck Cancer | 0 | 7 | 02-07-2026 |
| 3 | Comparison of Diet and Lifestyle Program With 3 Medication Approaches for Laryngopharyngeal Reflux Disease | 0 | 7 | 02-07-2026 |
| 4 | When alleging cause for dismissal becomes an employer's costliest mistake | 0 | 8.21 | 21-07-2026 |
| 5 | Women often opt for self-collection HPV screening, new studies show | 0 | 15.54 | 29-07-2026 |
| 6 | Neoadjuvant Immune Checkpoint Inhibitors in Early Breast Cancer | 0 | 7.64 | 01-10-2024 |
| 7 | Statistical test helps judge the value of personalization | 0 | 9.91 | 14-07-2026 |
| 8 | Recoverability of costs | 0 | 10 | 03-08-2026 |
| 9 | Healthcare affordability | 0 | 7.59 | 13-07-2026 |